Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Journals
  3. Infection Control & Hospital Epidemiology
  4. Accepted manuscripts
Journal Home
Refine listing

Refine listing

Access:

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

Accepted manuscripts

Contents

Original Article

  • Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings
  • Part of:
  • Gili Regev-Yochay, Or Kriger, Michael J. Mina, Sharon Beni, Carmit Rubin, Bella Mechnik, Sabrina Hason, Elad Biber, Bian Nadaf, Yitshak Kreiss, Sharon Amit
  • Published online by Cambridge University Press: 02 March 2022, pp. 1-20
  • View abstract
    Objective:

    To assess the validity of Antigen rapid diagnostic tests (Ag-RDT) for SARS-CoV-2 as decision support tool in various hospital-based clinical settings.

    Design:

    Retrospective cohort study among symptomatic and asymptomatic patients and Healthcare workers (HCW).

    Setting:

    A large tertiary teaching medical center serving as a major COVID-19 hospitalizing facility.

    Participants and Methods:

    Ag-RDTs’ performance was assessed in three clinical settings: 1. Symptomatic patients and HCW presenting at the Emergency Departments 2. Asymptomatic patients screened upon hospitalization 3. HCW of all sectors tested at the HCW clinic following exposure.

    Results:

    We obtained 5172 samples from 4595 individuals, who had both Ag-RDT and quantitative real-time PCR (qRT-PCR) results available. Of these, 485 samples were positive by qRT-PCR. The positive percent agreement (PPA) of Ag-RDT was greater for lower cycle threshold (Ct) values, reaching 93% in cases where Ct-value was <25 and 85% where Ct-value was <30. PPA was similar between symptomatic and asymptomatic individuals. We observed a significant correlation between Ct-value and time from infection onset (p<0.001).

    Conclusions:

    Ag-RDT are highly sensitive to the infectious stage of COVID-19 manifested by either high viral load (lower Ct) or proximity to infection, whether patient is symptomatic or asymptomatic. Thus, this simple-to-use and inexpensive detection method can be used as a decision support tool in various in-hospital clinical settings, assisting patient flow and maintaining sufficient hospital staffing.